CD8A and neoplasm: To determine whether high‐throughput sequencing of the TCRβ‐CDR3 region can assist in tracking tumor‐associated antigen‐specific T cells, we interrogated the clonal repertoire of EBV‐specific CD8+ T cells from a patient with EBV+ DLBCL.